NanOZ LNP-siRNA GAPDH
siRNA targeting GAPDH formulated in lipid nanoparticles.
NanOZ LNP-siRNA GAPDH is a ready-to-use siRNA targeting the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), encapsulated in lipid nanoparticles (LNPs) produced by microfluidic technology. It is a positive control to assess knockdown efficiency and to benchmark delivery platforms.
The LNPs are monodisperse, with a narrow size distribution and a high encapsulation efficiency (>80%). They are designed to protect the siRNA from degradation and to facilitate its intracellular uptake. GAPDH knockdown can be assessed by quantifying GAPDH mRNA.
Concentration: 400 nM siRNA in LNPs
Buffer: PBS, 10% sucrose
Sizes:
- LNP10250SIRNA2: 0.25 mL (5 x 50 µL)
- LNP10500SIRNA2: 0.5 mL (10 x 50 µL)
- LNP11000SIRNA2: 1 mL (20 x 50 µL)
Storage: -80°C. We recommend to minimize freeze-thaw cycles to preserve LNP integrity.
Shipping Conditions: Dry ice (Dry ice fee included in shipping cost).
This product is manufactured "on demand", which means that no stock is produced, so the expected delivery time is 2 to 3 weeks.
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| LNP10250SIRNA2 |
0.25 mL (5*50 µL) of LNP-siRNA GAPDH
|
$500.00
|
|
| LNP10500SIRNA2 |
0.5 mL (10*50 µL) of LNP-siRNA GAPDH
|
$900.00
|
|
| LNP11000SIRNA2 |
1 mL (20*50 µL) of LNP-siRNA GAPDH
|
$1,500.00
|
|
Citation database
Related products
NanOZ LNP-siRNA GFP
NanOZ LNP-siRNA
siRNA targeting GFP formulated in lipid nanoparticles
NanOZ LNP-siRNA NT Cy5
NanOZ LNP-siRNA
Cy5-labeled scrambled siRNA formulated in lipid nanoparticles
LNP D-Lin-MC3-DMA
NanOZ LNP-siRNA
Lipid nanoparticles with D-Lin-MC3-DMA ionizable lipid available with...